BD Launches AI-Driven Research Cloud 7.0 to Transform Scientific Workflow and Collaboration
- Becton Dickinson & Company launches BD® Research Cloud 7.0, featuring the AI-driven BD Horizon™ Panel Maker for research efficiency.
- The BD Horizon™ Panel Maker generates optimized panel recommendations quickly, improving data reliability and resource usage for researchers.
- BD aims to empower scientific discovery by integrating AI technology, enhancing operational efficiency in immunology and cancer research.
BD Unveils Advanced AI Tool to Enhance Research Efficiency
Becton, Dickinson and Company (BD) announces the global commercial launch of BD® Research Cloud 7.0, featuring the BD Horizon™ Panel Maker, an AI-driven tool aimed at revolutionizing scientific research in immunology and cancer. This innovative platform is designed to streamline the research workflow, promote collaboration among scientists, and manage critical laboratory operations, including instrument health and reagent procurement. The introduction of this cloud-based ecosystem signifies BD's commitment to advancing the capabilities of researchers and improving the quality of scientific results.
The BD Horizon™ Panel Maker stands out with its sophisticated AI algorithms that generate optimized panel recommendations within seconds. Researchers can utilize custom inputs or leverage validated databases to create tailored panels, addressing a common challenge in the field—poorly designed experimental panels that lead to unreliable data and wasted resources. By providing automated recommendations alongside integrated visualization tools such as comparison tables and complexity scores, the Panel Maker enables scientists to efficiently evaluate and select the most appropriate panels for their experiments, ultimately enhancing the reliability of their results.
Steve Conly, worldwide president of BD Biosciences, highlights the significance of these AI capabilities, stating that they are designed to help researchers gain high-quality insights in a fraction of the time, while reducing complexity and potential errors. The BD Horizon™ Panel Maker not only maximizes the efficacy of BD's advanced hardware, such as the BD FACSDiscover™ Cell Analyzer and Cell Sorters, but also reinforces the company’s leadership position in flow cytometry and life sciences research. This release marks a critical step in BD's ongoing mission to empower scientific discovery through innovative technology.
In addition to the BD Horizon™ Panel Maker, the BD® Research Cloud 7.0 offers a comprehensive platform for managing laboratory workflows. This release is timely, as the demand for efficient and reliable research tools continues to grow within the scientific community. With its focus on enhancing research quality and operational efficiency, BD is well-positioned to meet the evolving needs of scientists around the world.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

